可溶性程序性细胞死亡配体-1对脓毒症患者进展为慢性危重症的预测价值:一项前瞻性观察性临床研究
该前瞻性观察性研究纳入91例首次入住ICU的成人脓毒症患者,按临床结局分为慢性危重症组(CCI,ICU停留≥14天且持续器官功能障碍)和快速恢复组(RAP)。检测入院时及第7天血清sPD-L1水平,比较两组临床参数。结果显示脓毒症患者sPD-L1显著高于健康人,且与传统炎症标志物及疾病严重度评分正相关(P<0.05)。多因素回归中sPD-L1可独立预测第7天淋巴细胞减少(P<0.05)。59例(64.8%)为RAP,32例(35.2%)进展为CCI;CCI组年龄更大、病情更重、死亡率更高(P<0.05),第7天sPD-L1更高,预测CCI的AUC为0.782,与APACHE II评分0.708相当。
要点
- 脓毒症患者血清sPD-L1显著高于健康人,且与传统炎症标志物和疾病严重度评分正相关(P<0.05)。
- 多因素回归分析中,sPD-L1可独立预测第7天淋巴细胞减少(P<0.05)。
- 91例脓毒症患者中59例(64.8%)快速恢复,32例(35.2%)进展为慢性危重症(CCI)。
- 与RAP组相比,CCI组年龄更大、病情更重、死亡率更高(P<0.05)。
- 第7天sPD-L1预测CCI的AUC为0.782,与APACHE II评分0.708相当。
适用人群与场景
- 首次入住ICU的成人脓毒症患者,研究期间共筛查166例,最终纳入91例。
- 按临床结局分为CCI组(ICU停留≥14天且持续器官功能障碍)和快速恢复(RAP)组。
诊断标准与关键阈值
- 慢性危重症(CCI)定义:ICU停留≥14天且持续器官功能障碍。
- 快速恢复(RAP)组:根据临床结局划分,与CCI组相对应。
研究设计与关键结果
- 研究类型:前瞻性观察性临床研究;纳入91例首次入住ICU的成人脓毒症患者。
- 脓毒症患者sPD-L1水平显著高于健康个体,且与传统炎症标志物和疾病严重度评分正相关(P<0.05)。
- 多因素回归分析中,sPD-L1可独立预测第7天淋巴细胞减少(P<0.05)。
- 脓毒症队列中59例(64.8%)为快速恢复(RAP),32例(35.2%)进展为慢性危重症(CCI)。
- 与RAP组相比,CCI组平均年龄更高、疾病严重度更高、死亡率更高(P<0.05)。
- 第7天sPD-L1在CCI组仍更高,预测CCI的AUC为0.782,APACHE II评分AUC为0.708。
证据类型、等级与局限
- 证据类型:前瞻性观察性临床研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脓毒症感染严重度和免疫抑制可能与血清sPD-L1相关;第7天sPD-L1对预测患者进展为CCI有价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: As an immune marker, serum soluble programmed cell death ligand-1 (sPD-L1) is significantly increased in sepsis and is predictive of mortality. We investigated the prognostic value of sPD-L1 in postseptic immunosuppression and progression to chronic critical illness (CCI). Methods: Adults with sepsis in intensive care units (ICUs) for the first time were screened and assigned to either a CCI group (ICU stay ≥14 days with persistent organ dysfunction) or a rapid recovery (RAP) group based on clinical outcome. Data regarding basic admission information and clinical parameters were collected and compared across the two groups. Serum sPD-L1 levels were detected by enzyme-linked immunosorbent assay at admission and on the seventh day (D 7 ). Logistic regression analysis was used to determine the factors affecting septic patients' lymphocytopenia diagnosis on day 7 and CCI progression during hospitalization. The receiver operating characteristic curve and DeLong test were used to assess variable predictive power. Results: During the study period, a total of 166 septic patients were admitted to the ICU, and 91 septic patients were enrolled after screening. Compared with those in healthy individuals, the sPD-L1 levels in septic patients were significantly higher and positively correlated with traditional inflammatory markers and disease severity scores ( P < 0.05). In a multivariate regression analysis, sPD-L1 alone predicted lymphocytopenia on day 7 ( P < 0.05). In the sepsis cohort, 59 patients (64.8%) experienced RAP, and 32 patients (35.2%) developed CCI. Compared with the RAP group, the patients in the CCI group had a higher mean age, greater severity of disease, and higher mortality ( P < 0.05). D 7 -sPD-L1 remained higher in the CCI group, and the area under the curve that predicted the occurrence of CCI was equivalent to the APACHE II score, with areas under the curve of 0.782 and 0.708, respectively. Conclusions: The severity of infection and immunosuppression in sepsis may be linked to serum sPD-L1. D 7 -sPD-L1 is valuable in predicting the progression of CCI in patients.
参考来源
- Zeng C, Li X, Lu Z, et al. PREDICTIVE VALUE OF SOLUBLE PROGRAMMED CELL DEATH LIGAND-1 IN THE PROGRESSION OF SEPTIC PATIENTS TO CHRONIC CRITICAL ILLNESS IN THE INTENSIVE CARE UNIT: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY. Shock. 2023. PMID: 37267247. doi:10.1097/SHK.0000000000002156
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。